AtriCure, Inc. (ATRC)
ATRC Stock Price Chart
Explore AtriCure, Inc. interactive price chart. Choose custom timeframes to analyze ATRC price movements and trends.
ATRC Company Profile
Discover essential business fundamentals and corporate details for AtriCure, Inc. (ATRC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
5 Aug 2005
Employees
1.30k
Website
https://www.atricure.comCEO
Michael H. Carrel
Description
AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform tissue ablation with a single device. The Coolrail device facilitates the creation of longer linear ablation lines. For varying lengths of linear ablations, the CryoICE Cryoablation System is available. Furthermore, the EPi-Sense Guided Coagulation System is a single-use solution for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. AtriCure also provides systems for cardiac appendage management and soft-tissue closure. The AtriClip System is an implantable device accompanied by a disposable applier, while the LARIAT System offers a suture-based solution for soft-tissue closure, compatible with various anatomical shapes. Additionally, AtriCure offers supplementary surgical tools including Lumitip Dissectors, designed to separate tissues for optimal access, Glidepath guides for precise clamp placement, and Subtle Cannulas facilitating access for EPi-Sense catheters. A suite of reusable cardiac surgery instruments, crucial for procedures involving heart valve repair or replacement, is also available. The company distributes its offerings through a combination of independent distributors and direct sales personnel. Founded in 2000, AtriCure maintains its headquarters in Mason, Ohio.
ATRC Financial Timeline
Browse a chronological timeline of AtriCure, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Jul 2026
EPS estimate is $0.03, while revenue estimate is $151.84m.
Earnings released on 5 May 2026
EPS came in at $0.00 surpassing the estimated -$0.07 by +103.14%, while revenue for the quarter reached $141.25m , beating expectations by +1.08%.
Earnings released on 17 Feb 2026
EPS came in at $0.06 surpassing the estimated -$0.04 by +249.89%, while revenue for the quarter reached $140.50m , beating expectations by +0.56%.
Earnings released on 29 Oct 2025
EPS came in at -$0.01 surpassing the estimated -$0.11 by +90.91%, while revenue for the quarter reached $134.27m , missing expectations by -4.43%.
Earnings released on 29 Jul 2025
EPS came in at -$0.02 surpassing the estimated -$0.15 by +86.67%, while revenue for the quarter reached $136.14m , beating expectations by +4.65%.
Earnings released on 29 Apr 2025
EPS came in at -$0.14 surpassing the estimated -$0.25 by +44.00%, while revenue for the quarter reached $123.62m , missing expectations by -5.34%.
Earnings released on 12 Feb 2025
EPS came in at -$0.08 surpassing the estimated -$0.23 by +65.22%, while revenue for the quarter reached $124.28m , beating expectations by +2.00%.
Earnings released on 29 Oct 2024
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%, while revenue for the quarter reached $115.91m , missing expectations by -3.29%.
Earnings released on 30 Jul 2024
EPS came in at -$0.17 falling short of the estimated -$0.15 by -13.33%, while revenue for the quarter reached $116.27m , beating expectations by +0.08%.
Earnings released on 1 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $108.85m , beating expectations by +1.83%.
Earnings released on 15 Feb 2024
EPS came in at -$0.21 surpassing the estimated -$0.22 by +4.55%, while revenue for the quarter reached $106.54m , beating expectations by +2.76%.
Earnings released on 1 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%, while revenue for the quarter reached $98.29m , beating expectations by +1.61%.
Earnings released on 25 Jul 2023
EPS came in at -$0.12 surpassing the estimated -$0.27 by +55.56%, while revenue for the quarter reached $100.92m , beating expectations by +4.70%.
Earnings released on 2 May 2023
EPS came in at -$0.23 surpassing the estimated -$0.34 by +32.35%, while revenue for the quarter reached $93.49m , beating expectations by +6.81%.
Earnings released on 21 Feb 2023
EPS came in at -$0.09 surpassing the estimated -$0.18 by +50.00%, while revenue for the quarter reached $88.03m , beating expectations by +0.28%.
Earnings released on 1 Nov 2022
EPS came in at -$0.27 falling short of the estimated -$0.25 by -8.00%, while revenue for the quarter reached $83.25m , beating expectations by +1.78%.
Earnings released on 2 Aug 2022
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%, while revenue for the quarter reached $84.53m , beating expectations by +6.19%.
Earnings released on 3 May 2022
EPS came in at -$0.33 falling short of the estimated -$0.27 by -22.22%, while revenue for the quarter reached $74.58m , beating expectations by +4.79%.
Earnings released on 15 Feb 2022
EPS came in at -$0.30 falling short of the estimated -$0.26 by -15.38%, while revenue for the quarter reached $73.22m , beating expectations by +0.77%.
Earnings released on 3 Nov 2021
EPS came in at $2.11 surpassing the estimated -$0.32 by +759.37%, while revenue for the quarter reached $70.46m , beating expectations by +2.59%.
Earnings released on 4 Aug 2021
EPS came in at -$0.36 falling short of the estimated -$0.33 by -9.09%, while revenue for the quarter reached $71.38m , beating expectations by +16.88%.
ATRC Stock Performance
Access detailed ATRC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
